Coastal Investment Advisors, Inc. Immuno Gen, Inc. Transaction History

Coastal Investment Advisors, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 23, 2020	SELL	$2.12 - $6.8 $398 - $1,278	-188 Closed	0 $0
Q3 2019 Oct 18, 2019	SELL	$2.22 - $3.39 $1,600 - $2,444	-721 Reduced 79.32%	188 $0
Q2 2019 Aug 01, 2019	BUY	$1.8 - $3.3 $1,297 - $2,379	721 Added 383.51%	909 $2,000
Q1 2019 May 15, 2019	BUY	$2.41 - $5.91 $453 - $1,111	188 New	188 $0

1.41M

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

Get notified when there are updates to the investment portfolio of Coastal Investment Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Coastal Investment Advisors, Inc. with notifications on news.